Trials / Conditions / Mevalonate Kinase Deficiency
Mevalonate Kinase Deficiency
4 registered clinical trials studyying Mevalonate Kinase Deficiency — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Geranylgeraniol Supplementation in Patients With Mevalonate Kinase Deficiency NCT06497829 | University Hospital, Motol | N/A |
| Withdrawn | B7 Coreceptor Molecules in Hyper IgD Syndrome Form of Mevalonate Kinase Deficiency NCT01568736 | Michigan Technological University | — |
| Completed | Canakinumab in Patients With Active Hyper-IgD Syndrome NCT01303380 | Novartis Pharmaceuticals | Phase 2 |
| Terminated | Dietary Cholesterol and Defects in Cholesterol Synthesis in Mevalonate Kinase Deficiency NCT00260299 | Oregon Health and Science University | — |